AIMing for services

Horizon Discovery Group plc is following the lead of other U.K. life science services companies by listing on the LSE's AIM rather heading to the U.S. The company says AIM will provide sufficient cash without the more onerous reporting requirements and far-flung roadshows that would come with a U.S. listing.

Last month, Horizon announced plans to raise up to £25 million ($41.6 million) in its IPO, with Panmure Gordon as advisor and broker...